Home/Filings/4/0000930413-10-000586
4//SEC Filing

KRENITSKY KEVIN 4

Accession 0000930413-10-000586

CIK 0000316253other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 8:15 PM ET

Size

5.0 KB

Accession

0000930413-10-000586

Insider Transaction Report

Form 4
Period: 2010-01-29
KRENITSKY KEVIN
President, Enzo Clinical Labs
Transactions
  • Award

    Common Stock, par value $0.01

    2010-01-29+6,00017,600 total
Footnotes (1)
  • [F1]The Reporting Person was granted 6,000 shares of restricted common stock, par value $0.01 per share, of the Company on January 29, 2010 in connection with his service as an officer of the Company. The shares will vest in three equal annual installments, beginning on January 29, 2011.

Documents

1 file

Issuer

ENZO BIOCHEM INC

CIK 0000316253

Entity typeother

Related Parties

1
  • filerCIK 0001457809

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 8:15 PM ET
Size
5.0 KB